Dr. Mirza on Efficacy of Niraparib/Bevacizumab Combo in Recurrent Ovarian Cancer OncLive 2:18 5 years ago 299 Далее Скачать
Dr. Mirza on Niraparib Plus Bevacizumab Combo in Ovarian Cancer OncLive 1:41 7 years ago 310 Далее Скачать
Dr. Mirza on Safety Profile of Niraparib/Bevacizumab in Recurrent Ovarian Cancer OncLive 0:52 4 years ago 112 Далее Скачать
Dr. Mirza on Niraparib Efficacy Across Ovarian Cancer Subgroups OncLive 1:30 7 years ago 221 Далее Скачать
Dr. Mirza Discusses Niraparib Dose Modifications for Ovarian Cancer Patients With Low Body Weight OncLive 2:26 6 years ago 394 Далее Скачать
Dr. Mirza on the Rationale for the AVANOVA Trial in Recurrent Ovarian Cancer OncLive 2:11 5 years ago 197 Далее Скачать
Combination therapy to treat ovarian cancer: promising results from the ANANOVA trial VJOncology 2:17 7 years ago 71 Далее Скачать
Results of Niraparib/Bevacizumab Combo in Platinum-Sensitive Recurrent Ovarian Cancer Targeted Oncology 2:25 5 years ago 301 Далее Скачать
Dr. Mirza on the Evolving Treatment Landscape in Recurrent Ovarian Cancer OncLive 1:30 4 years ago 177 Далее Скачать
Results from the ENGOT-OV16/NOVA trial: efficacy and safety of niraparib in ovarian cancer VJOncology 9:25 8 years ago 1 172 Далее Скачать
Final ANANOVA2 Survival Data Support Niraparib Plus Bevacizumab in Recurrent Ovarian Cancer Targeted Oncology 1:42 4 years ago 174 Далее Скачать
The AVANOVA study: niraparib and bevacizumab for ovarian cancer VJOncology 3:11 5 years ago 258 Далее Скачать
Dr. Arend on Niraparib With Bevacizumab in Ovarian Cancer OncLive 1:14 6 years ago 1 031 Далее Скачать
Efficacy of Niraparib on PFS in Patients With Recurrent Ovarian Cancer Targeted Oncology 0:43 7 years ago 159 Далее Скачать
Niraparib Shows Positive Data, Requires Different Dosing in Ovarian Cancer Targeted Oncology 1:50 4 years ago 516 Далее Скачать
Combination Therapy With Niraparib and Bevacizumab for Ovarian Cancer Targeted Oncology 7:19 5 years ago 118 Далее Скачать
